Taipei, Taiwan

Chiayn Chiang

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Taigen Biotechnology Company, Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiayn Chiang. Retrieved from https://idiyas.com/inventor/chiayn-chiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chiayn Chiang

Introduction

Chiayn Chiang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compounds. His work focuses on innovative solutions for treating viral infections.

Latest Patents

Chiayn Chiang holds a patent for a compound known as cap-dependent endonuclease inhibitors. This compound is described by a specific formula and includes various components that can be used to treat influenza. The patent outlines the use of this compound, along with its pharmaceutically acceptable salts, metabolites, or prodrugs, in pharmaceutical compositions aimed at combating viral infections.

Career Highlights

Chiayn Chiang is associated with Taigen Biotechnology Company, Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that address pressing health concerns.

Collaborations

Chiayn has collaborated with esteemed colleagues such as Chu-Chung Lin and Hung-Chuan Chen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Chiayn Chiang's contributions to biotechnology and his innovative patent for treating influenza highlight his role as a key inventor in the field. His ongoing work promises to lead to further advancements in pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…